Outcomes of adjuvant mitotane after resection of adrenocortical carcinoma: a 13-institution study by the US Adrenocortical Carcinoma Group

LM Postlewait, CG Ethun, TB Tran, JD Prescott… - Journal of the American …, 2016 - Elsevier
Background Current treatment guidelines recommend adjuvant mitotane after resection of
adrenocortical carcinoma with high-risk features (eg, tumor rupture, positive margins …
被引用次数：91 相关文章

Outcomes of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A 13-Institution Study by the US Adrenocortical Carcinoma Group

LM Postlewait, CG Ethun, TB Tran… - Journal of the …, 2016 - ohiostate.elsevierpure.com
Background Current treatment guidelines recommend adjuvant mitotane after resection of
adrenocortical carcinoma with high-risk features (eg, tumor rupture, positive margins …

Outcomes of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A 13-Institution Study by the US Adrenocortical Carcinoma Group

LM Postlewait, CG Ethun, TB Tran… - Journal of the …, 2016 - profiles.wustl.edu
Background Current treatment guidelines recommend adjuvant mitotane after resection of
adrenocortical carcinoma with high-risk features (eg, tumor rupture, positive margins …

Outcomes of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A 13-Institution Study by the US Adrenocortical Carcinoma Group

LM Postlewait, CG Ethun, TB Tran… - Journal of the …, 2016 - journals.lww.com
Background Current treatment guidelines recommend adjuvant mitotane after resection of
adrenocortical carcinoma with high-risk features (eg, tumor rupture, positive margins …

Outcomes of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A 13-Institution Study by the US Adrenocortical Carcinoma Group.

LM Postlewait, CG Ethun, TB Tran… - Journal of the …, 2015 - europepmc.org
Background Current treatment guidelines recommend adjuvant mitotane after resection of
adrenocortical carcinoma with high-risk features (eg, tumor rupture, positive margins …

Outcomes of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A 13-Institution Study by the US Adrenocortical Carcinoma Group

LM Postlewait, CG Ethun… - Journal of the …, 2016 - utsouthwestern.elsevierpure.com
Background Current treatment guidelines recommend adjuvant mitotane after resection of
adrenocortical carcinoma with high-risk features (eg, tumor rupture, positive margins …

Outcomes of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A 13-Institution Study by the US Adrenocortical Carcinoma Group

LM Postlewait, CG Ethun, TB Tran… - Journal of the …, 2016 - pubmed.ncbi.nlm.nih.gov
Background Current treatment guidelines recommend adjuvant mitotane after resection of
adrenocortical carcinoma with high-risk features (eg, tumor rupture, positive margins …

Outcomes of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A 13-Institution Study by the US Adrenocortical Carcinoma Group.

LM Postlewait, CG Ethun, TB Tran… - Journal of the …, 2016 - escholarship.org
BackgroundCurrent treatment guidelines recommend adjuvant mitotane after resection of
adrenocortical carcinoma with high-risk features (eg, tumor rupture, positive margins …

Outcomes of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A 13-Institution Study by the US Adrenocortical Carcinoma Group

LM Postlewait, CG Ethun, TB Tran… - Journal of the …, 2016 - pure.johnshopkins.edu
Background Current treatment guidelines recommend adjuvant mitotane after resection of
adrenocortical carcinoma with high-risk features (eg, tumor rupture, positive margins …

Outcomes of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A 13-Institution Study by the US Adrenocortical Carcinoma Group

LM Postlewait, CG Ethun, TB Tran, JD Prescott… - Journal of the American …, 2016 - infona.pl
Current treatment guidelines recommend adjuvant mitotane after resection of adrenocortical
carcinoma with high-risk features (eg, tumor rupture, positive margins, positive lymph nodes …